Market Cap 19.80M
Revenue (ttm) 28.54M
Net Income (ttm) -39.26M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -137.56%
Debt to Equity Ratio -0.92
Volume 11,800
Avg Vol 284,314
Day's Range N/A - N/A
Shares Out 12.30M
Stochastic %K 11%
Beta 0.69
Analysts Sell
Price Target $4.00

Company Profile

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People's Republic of China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation and as a palliative treatment for patients with multiple myeloma. The company's hematology/oncology assets in pipeline include CNCT19, an autologous CD19 CAR-T investiga...

Industry: Biotechnology
Sector: Healthcare
Phone: 86 10 6508 6063
Address:
1701-1702, China Central Office Tower 1, No. 81 Jianguo Road Chaoyang District, Beijing, China
eddiez69
eddiez69 Oct. 23 at 6:54 PM
$IMMX Volume on this indicates institutional accumulation. Long and strong! YO Small Cap Traders - you MUST LOOK at $CASI - mkt cap is $25.26 Million with only 1.84 Millions shares in float. The team is a who's who in biotech deals with David Cory, new CEO having brought many drugs to market and multiple Billion $ buyouts at other biotechs. Private Placement recently completed on 9/26 at higher price - Panacea and James Huang’s combined effective average cost is about $1.83 per share. No cash issues. Seriously big market for their drug. IMO this is a $7 stock easily See their 13D on edgar https://app.quotemedia.com/data/downloadFiling?webmasterId=102691&ref=319477051&type=HTML&symbol=CASI&cdn=9441db26338e6caf804c7ff41b11286b&companyName=CASI+Pharmaceuticals+Inc.&formType=SCHEDULE+13D&formDescription=General+statement+of+acquisition+of+beneficial+ownership&dateFiled=2025-09-26
0 · Reply
JGroove
JGroove Oct. 22 at 12:53 PM
$CASI guess I am bag holding until the next run
0 · Reply
JGroove
JGroove Oct. 15 at 3:24 PM
$CASI queued
0 · Reply
BullishPiggy
BullishPiggy Oct. 13 at 9:15 PM
$CASI whats this AH bullshit
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 9 at 8:00 PM
9/26/25 list Results $CACC $CASI $CADE $CAE $CAG 🔥 Cycle Trading Signal plugged into AI 🔥 list
0 · Reply
eddiez69
eddiez69 Oct. 8 at 4:40 PM
$IMMX This is easily a $200M to $400M market cap making it a potential $6 to $12 stock in the near-term. Check out $CASI also - its trading with just $30M market cap now with just 16M shares in the float- this is another one that could 3x to 5x in price
1 · Reply
StockScanners
StockScanners Oct. 4 at 3:41 PM
$CASI reached 2.07, lets go
0 · Reply
PharmaExpert
PharmaExpert Oct. 3 at 5:50 PM
$AKBA, $ANRO, $NEUP, $EVAX, $CASI 🔥🔥🔥🔥🔥
1 · Reply
StockScanners
StockScanners Oct. 3 at 2:56 AM
$CASI reached 1.92
0 · Reply
StockScanners
StockScanners Oct. 2 at 12:51 AM
$CASI reached 1.75
0 · Reply
Latest News on CASI
CASI Pharmaceuticals Appoints James Huang to Board of Directors

Sep 26, 2025, 9:45 AM EDT - 4 weeks ago

CASI Pharmaceuticals Appoints James Huang to Board of Directors


CASI Pharmaceuticals Provides Business and Clinical Update

May 19, 2025, 9:00 AM EDT - 5 months ago

CASI Pharmaceuticals Provides Business and Clinical Update


CASI PHARMACEUTICALS COMPLETES REDOMICILIATION MERGER

Mar 21, 2023, 4:30 PM EDT - 2 years ago

CASI PHARMACEUTICALS COMPLETES REDOMICILIATION MERGER


eddiez69
eddiez69 Oct. 23 at 6:54 PM
$IMMX Volume on this indicates institutional accumulation. Long and strong! YO Small Cap Traders - you MUST LOOK at $CASI - mkt cap is $25.26 Million with only 1.84 Millions shares in float. The team is a who's who in biotech deals with David Cory, new CEO having brought many drugs to market and multiple Billion $ buyouts at other biotechs. Private Placement recently completed on 9/26 at higher price - Panacea and James Huang’s combined effective average cost is about $1.83 per share. No cash issues. Seriously big market for their drug. IMO this is a $7 stock easily See their 13D on edgar https://app.quotemedia.com/data/downloadFiling?webmasterId=102691&ref=319477051&type=HTML&symbol=CASI&cdn=9441db26338e6caf804c7ff41b11286b&companyName=CASI+Pharmaceuticals+Inc.&formType=SCHEDULE+13D&formDescription=General+statement+of+acquisition+of+beneficial+ownership&dateFiled=2025-09-26
0 · Reply
JGroove
JGroove Oct. 22 at 12:53 PM
$CASI guess I am bag holding until the next run
0 · Reply
JGroove
JGroove Oct. 15 at 3:24 PM
$CASI queued
0 · Reply
BullishPiggy
BullishPiggy Oct. 13 at 9:15 PM
$CASI whats this AH bullshit
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 9 at 8:00 PM
9/26/25 list Results $CACC $CASI $CADE $CAE $CAG 🔥 Cycle Trading Signal plugged into AI 🔥 list
0 · Reply
eddiez69
eddiez69 Oct. 8 at 4:40 PM
$IMMX This is easily a $200M to $400M market cap making it a potential $6 to $12 stock in the near-term. Check out $CASI also - its trading with just $30M market cap now with just 16M shares in the float- this is another one that could 3x to 5x in price
1 · Reply
StockScanners
StockScanners Oct. 4 at 3:41 PM
$CASI reached 2.07, lets go
0 · Reply
PharmaExpert
PharmaExpert Oct. 3 at 5:50 PM
$AKBA, $ANRO, $NEUP, $EVAX, $CASI 🔥🔥🔥🔥🔥
1 · Reply
StockScanners
StockScanners Oct. 3 at 2:56 AM
$CASI reached 1.92
0 · Reply
StockScanners
StockScanners Oct. 2 at 12:51 AM
$CASI reached 1.75
0 · Reply
jenyz20
jenyz20 Oct. 1 at 2:30 PM
$PALI $BBLG $CASI $ISPC $MSPR next swing watchlist posted 9/28 all hit but mspr
0 · Reply
Nova_Trades
Nova_Trades Oct. 1 at 5:37 AM
Winner Wednesday Watchlist Pt. 5: $QCLS $CASI $AKBA $MTEX $VIVK ⚡️ Closing out the month strong and stepping into a brand-new one tomorrow—fresh setups, fresh momentum, and fresh opportunities. Let’s make it count and level up from day one! 🚀📈
0 · Reply
Stock_Catcher
Stock_Catcher Oct. 1 at 1:25 AM
Winner Wednesday Watchlist Pt. 5 $QCLS $CASI $AKBA $MTEX $VIVK Brand New Month Tomorrow Let's GO! 🎃
0 · Reply
StockScanners
StockScanners Oct. 1 at 1:23 AM
$CASI keep watch if this holds above 1.45
0 · Reply
Win00888
Win00888 Sep. 30 at 9:00 PM
$ATCH welcome to here for joining the Atch Army $ANAB $BKKT $CASI $SPRC $WOLF
0 · Reply
Win00888
Win00888 Sep. 30 at 8:59 PM
$ANAB $BKKT $CASI $SPRC $WOLF Welcome to join our $ATCH Army
0 · Reply
topstockalerts
topstockalerts Sep. 30 at 8:54 PM
Top Gainers PT2 $SPRC $BKKT $ANAB $WOLF $CASI
0 · Reply
topstockalerts
topstockalerts Sep. 30 at 8:10 PM
Top Gainers PT2 $SPRC $SKYQ $ANAB $BKKT $CASI
0 · Reply
Raxothus
Raxothus Sep. 30 at 7:42 PM
EOD CONTINUATION WATCHLIST – 09/30/25 Focused on stocks that held VWAP and pushed into Power Hour with strength $CASI – 6.5x volume, 20.2% VWAP stretch, micro float (4.5M) 21.4% open-to-current with 19.6% late push, RSI 56.7. Strong candidate, watching breakout > 1.66 for continuation. $IMA – 4.6x volume, 4.4% VWAP stretch, small float (10.1M) 5.4% open-to-current with 0.1% late push, RSI 49.0. Watching breakout > 8.39 for continuation. $FATE – 6.4x volume, 2.2% VWAP stretch, medium float (100.8M) 17.6% open-to-current with 4.2% late push, RSI 51.5. Watching breakout > 1.27 for continuation. $GKPRF – 0.9x volume, 4.7% VWAP stretch, medium float (89.2M) 17.1% open-to-current with 0.0% late push, RSI 59.7. Needs breakout > 1.66 for continuation. #EOD #VWAP #Momentum #SmallCaps #DayTrading #ContinuationSetups #PowerHourWatch
0 · Reply
DARKP00L
DARKP00L Sep. 30 at 3:41 PM
$CASI this stock is attracting a lot of interest. Be prepared for possible changes!
1 · Reply
eddiez69
eddiez69 Sep. 29 at 3:22 PM
$CASI From Friday's 13-D Filing On September 26, 2025, Panacea Venture Healthcare Fund II, L.P. purchased 1,500,000 Ordinary Shares from the Issuer at a price of $1.5350 per Ordinary Share. If you combine all of Huang's and Panacea purchases and dilute with the warrants then their average cost is 1.83 -
0 · Reply
AZOZ
AZOZ Sep. 29 at 1:06 PM
$CASI Oversold swing idea!
0 · Reply